Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Cadrenal Therapeutics, Inc. (CVKD) AI Forecast

Our AI analyzed Cadrenal Therapeutics, Inc.. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$CVKD Neutral Signal Full forecast available
Sign Up Free

Cadrenal Therapeutics, Inc. (CVKD) Stock Forecast 2025

Cadrenal Therapeutics, Inc. (CVKD) AI Stock Price Forecast & Investment Analysis

Cadrenal Therapeutics, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Cadrenal Therapeutics, Inc. (CVKD) - Comprehensive Stock Analysis & Investment Research

Deep dive into Cadrenal Therapeutics, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 28, 2026, 11:02 p.m. (UTC)

Cadrenal Therapeutics, Inc. Investment Summary

When evaluating whether Cadrenal Therapeutics, Inc. (CVKD) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Cadrenal Therapeutics, Inc. (CVKD) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $6 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Cadrenal Therapeutics, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Cadrenal Therapeutics, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Cadrenal Therapeutics, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Cadrenal Therapeutics, Inc.

Sign Up Free
Corporate Identity

Cadrenal Therapeutics, Inc. (Stock Symbol: CVKD) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Cadrenal Therapeutics, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Cadrenal Therapeutics, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Cadrenal Therapeutics, Inc....

Unlock Full Company Profile

Get complete details about Cadrenal Therapeutics, Inc.

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Cadrenal Therapeutics, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Cadrenal Therapeutics, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Cadrenal Therapeutics, Inc....

Unlock Financial Analysis

Get complete financial metrics for Cadrenal Therapeutics, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Cadrenal Therapeutics, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Cadrenal Therapeutics, Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Cadrenal Therapeutics, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-11 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Financial Strength & Leverage

Cadrenal Therapeutics, Inc. (CVKD) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Cadrenal Therapeutics, Inc. stock analysis.

Deep dive into Cadrenal Therapeutics, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Cadrenal Therapeutics, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Cadrenal Therapeutics, Inc.:

P/B Ratio 3.55x
Market Cap $6M
EPS $-0.85
Book Value/Share $0.58
FCF/Share $-3.42
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Cadrenal Therapeutics, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Cadrenal Therapeutics, Inc.: An ROE of -373.6% indicates room for improvement in shareholder value creation.

ROE -373.6%
ROA -234.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Cadrenal Therapeutics, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Cadrenal Therapeutics, Inc.:

D/E Ratio 0.59x
Financial Leverage 1.59x
Interest Coverage -1188.5x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Cadrenal Therapeutics, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Cadrenal Therapeutics, Inc.: Free cash flow of $-11M indicates cash challenges that need attention.

Operating Cash Flow -$1M
Free Cash Flow -$11M
Capital Spending -$9M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Cadrenal Therapeutics, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Cadrenal Therapeutics, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Cadrenal Therapeutics, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Cadrenal Therapeutics, Inc.:

Income Statement
Operating Income -$2M
Net Income -$6M
R&D Expense $140K
Balance Sheet Highlights (% Of Assets)
Total Liabilities 1%
Dividend & Shareholder Information
Shares Outstanding 3M
Growth Metrics (YoY)
EPS Growth -41.2%

Latest Cadrenal Therapeutics, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Cadrenal Therapeutics, Inc. (CVKD) stock price and investment outlook.

📰 Loading...

Cadrenal Therapeutics, Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Cadrenal Therapeutics, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AARD ██% $140M x 1.6x
ABBV ██% $466.15B 128.2x x
ABCL ██% $1.61B x 1.7x
ABEO ██% $342M 5.2x 2.4x
ABT ██% $186.84B 29.8x 3.6x
ABUS ██% $869M 5.4x 3.3x
ABVC ██% $27M x 2.5x
ABVX ██% $9.76B x x
ACAD ██% $4.45B 11.9x 3.6x
ACET ██% $77M x 0.6x
ACRS ██% $744M x 5.2x
ACRV ██% $60M x 0.6x
ACUT ██% $4M x x
ACXP ██% $6M x 0.9x
ADAG ██% $246M x 6.5x
ADCT ██% $141M x x
ADIL ██% $6M x 1.7x
ADTX ██% $3M x x
ADXN ██% $7M x x
AEON ██% $11M x x
AGIO ██% $2.14B x 1.9x
AKBA ██% $340M x 12.4x
AKTX ██% $15M x 1.0x
ALDX ██% $95M x 2.3x
ALKS ██% $8.46B 128.0x 4.7x
ALLR ██% $19M x 2.7x
ALMS ██% $3.38B x 6.0x
ALNY ██% $38.18B 121.7x 48.4x
ALT ██% $581M x 2.1x
ALXO ██% $268M x 1.8x
ALZN ██% $5M x 6.8x
AMLX ██% $2.17B x 8.0x
AMPH ██% $899M 11.4x 1.2x
AMRN ██% $293M x 0.7x
AMRX ██% $5.93B 48.6x x
ANAB ██% $1.51B x 118.7x
ANEB ██% $14M x 1.7x
ANIP ██% $1.69B 18.4x 3.0x
ANIX ██% $119M x 8.3x
ANNX ██% $757M x 3.7x
ANRO ██% $961M x 4.0x
ANTX ██% $169M x 2.1x
ANVS ██% $72M x 23.0x
APLM ██% $40M x x
APRE ██% $7M x 0.2x
APUS ██% $12M x 0.1x
APVO ██% $5M x 0.4x
AQST ██% $467M x x
ARCT ██% $163M x 0.9x
ARDX ██% $1.26B x 8.5x
ARQT ██% $3.55B x 18.7x
ARTL ██% $3M x 0.5x
ARVN ██% $529M x 1.4x
ARWR ██% $12.06B x 19.6x
ASBP ██% $9M x 2.4x
ASMB ██% $507M x 2.6x
ASND ██% $15.77B x x
ASRT ██% $151M x 2.0x
ATAI ██% $2.66B x 16.6x
ATHE ██% $83M x x
ATNM ██% $27M x 11.8x
ATOS ██% $24M x 0.8x
ATXI ██% $990K x 0.8x
AUPH ██% $1.96B 6.6x 3.5x
AVBP ██% $1.36B x 4.2x
AVIR ██% $361M x 1.5x
AVTX ██% $1.03B x 15.1x
AXIM ██% $1M x x
AXSM ██% $12.04B x 220.6x
AZTR ██% $2M x 0.2x
BBIO ██% $16.74B x x
BBOT ██% $688M x 1.9x
BCAX ██% $1.76B x 3.4x
BCTX ██% $30M x 1.3x
BCYC ██% $275M x 0.5x
BDPT ██% $30K x x
BDRX ██% $1M x x
BFRG ██% $11M x 2.2x
BFRI ██% $13M x 2.2x
BHC ██% $1.69B x x
BHST ██% $46M x 1.8x
BIOA ██% $973M x 2.6x
BIOE ██% $13M 9.7x x
BIOM ██% $380K x x
BIVI ██% $10M x 0.6x
BIXT ██% $3M x x
BLRX ██% $13M x x
BLTE ██% $6.14B x 8.0x
BMEA ██% $90M x 4.8x
BMRN ██% $11.65B 43.3x 1.9x
BMY ██% $129.62B 17.8x 6.5x
BNTC ██% $414M x 2.3x
BOLD ██% $55M x 0.6x
BOLT ██% $8M x 0.4x
BPTH ██% $2M x x
BQST ██% $2M x x
BRNS ██% $25M x 0.4x
BSPK ██% $10K x x
BTAI ██% $27M x x
BYSI ██% $48M x x
CALC ██% $11M x x
CANF ██% $7M x 1.2x
CAPR ██% $403M x 1.5x
CATX ██% $322M x 0.9x
CBIO ██% $626M x 6.2x
CDT ██% $2M x x
CING ██% $61M x 3.2x
CLCS ██% $65M x x
CLNN ██% $64M x x
CLRB ██% $20M x 5.9x
CLSDQ ██% $1M x x
CLYM ██% $732M x 5.0x
CMMB ██% $10M x 0.8x
CMND ██% $2M x x
CMPS ██% $1.52B x 4.7x
CNBX ██% N/A x x
CNSP ██% $7M x 104.8x
CNTA ██% $6.27B x 12.9x
CNTB ██% $132M x 3.1x
CNTX ██% $57M x 1.1x
COCP ██% $13M x 3.2x
COGT ██% $6.91B x 11.4x
COLL ██% $1.16B 15.5x 3.7x
CORT ██% $9.52B 201.0x 14.9x
COYA ██% $100M x 2.0x
CPHI ██% $50M x 1.4x
CPIX ██% $103M x 4.8x
CPMD ██% $1M x x
CPRX ██% $3.85B 17.4x 3.8x
CRBP ██% $161M x 1.3x
CRMD ██% $596M 3.3x 1.4x
CRNX ██% $8.83B x 6.9x
CRVO ██% $25M x 2.3x
CRVS ██% $1.09B x 4.5x
CTMX ██% $708M x 2.2x
CTNM ██% $518M x 2.1x
CTOR ██% $52M x 1.5x
CTTH ██% $4M x 5.3x
CTXR ██% $14M x 0.2x
CUE ██% $131M x 6.1x
CURX ██% $5M x 0.6x
CVKD ██% $6M x 3.6x
CVSI ██% $4M x 2.6x
CYCN ██% $15M x 2.2x
CYDY ██% $270M x x
CYPH ██% $67M x 0.8x
CYRX ██% $766M 9.6x 1.6x
CYTK ██% $10.95B x x
DARE ██% $19M x 26.2x
DCOY ██% $2M x 0.5x
DERM ██% $174M x 5.6x
DMAC ██% $363M x 7.7x
DMRA ██% $1.80B x 3.5x
DNTH ██% $5.70B x 4.8x
DRMA ██% $5M x 0.8x
DRUG ██% $706M x x
DSGN ██% $742M x 3.4x
DWTX ██% $51M x 0.6x
DYN ██% $4.23B x 4.9x
EBS ██% $380M x 0.7x
EDSA ██% $48M x 4.7x
ELAB ██% $4M x 0.3x
ELAN ██% $12.69B x 2.0x
ELDN ██% $271M x 6.1x
ELTP ██% $409M 9.1x 4.1x
ELTX ██% $79M x x
ELVN ██% $3.77B x 8.3x
EMMA ██% $820K x x
ENLV ██% $72M 0.0x 0.0x
ENSC ██% $4M x x
ENTA ██% $370M x 3.2x
ENVB ██% $5M x 1.1x
EOLS ██% $401M x x
EPRX ██% $403M x 4.9x
EQ ██% $149M x 2.5x
ERAS ██% $6.55B x 16.6x
ERNA ██% $5M x 0.7x
ESPR ██% $799M x x
ETON ██% $1.16B x 37.8x
ETST ██% $35M 7.2x 5.0x
EVFM ██% $1M x x
EVMN ██% $413M x 1.4x
EWTX ██% $4.35B x 8.8x
FBIO ██% $109M 0.9x 0.7x
FBLG ██% $3M x 1.3x
FBRX ██% $1.57B x 37.3x
FHTX ██% $305M x x
FLNA ██% $44M x 0.6x
FTH ██% $754M x x
FULC ██% $248M x 0.7x
GALT ██% $223M x x
GANX ██% $79M x 5.6x
GCAN ██% $260K x x
GDTC ██% $11M x x
GERN ██% $956M x 4.2x
GHRS ██% $1.73B x x
GLMD ██% $3M x 0.2x
GLSI ██% $197M x 37.4x
GNLX ██% $132M x 5.8x
GNPX ██% $4M x 0.2x
GOSS ██% $97M x x
GOVX ██% $4M x 2.3x
GPCR ██% $3.46B x 2.4x
GRCE ██% $38M x 0.6x
GRI ██% $2M x 0.2x
GRTX ██% $3.38B 22.7x 4646.0x
GSK ██% $104.11B x x
GTBP ██% $12M x 1.6x
GYRE ██% $683M x 6.8x
HCM ██% $1.92B 2.1x 1.6x
HCWB ██% $4M x 0.8x
HELP ██% $477M x x
HEPA ██% $1M x 0.7x
HIND ██% $14M x 2.1x
HOOK ██% $14M x 0.4x
HOWL ██% $22M x 1.8x
HRMY ██% $2.06B 14.2x 2.3x
HRTX ██% $87M x 9.6x
HSTC ██% $99M x 79.9x
HURA ██% $141M x 6.1x
HYFT ██% $67M x x
HYPD ██% $39M x 0.7x
IBIO ██% $72M x 0.9x
IBO ██% $47M x 4.1x
IDYA ██% $3.16B x 3.4x
IFRX ██% $250M x x
IGC ██% $26M x 4.2x
IMMP ██% $56M x x
IMMX ██% $619M x 7.3x
IMNM ██% $2.56B x 4.3x
IMNN ██% $6M x 1.8x
IMRN ██% $9M x x
IMRX ██% $282M x 1.4x
IMUX ██% $188M x 1.2x
INBP ██% $5M x 0.3x
INDP ██% $272M x 217.8x
INDV ██% $4.96B 19.7x x
INM ██% $9M x 1.3x
INO ██% $80M x 13.2x
INSM ██% $22.68B x 32.2x
INTI ██% $14M x x
INVA ██% $1.62B 3.2x 1.2x
IOBTQ ██% $70K x 0.1x
IONS ██% $9.28B x 18.9x
IRD ██% $277M x x
IRON ██% $2.82B x 4.1x
IRWD ██% $644M 6.3x x
ISCO ██% $2M x x
IVA ██% $1.09B x x
IXHL ██% $36M x 0.5x
JAGX ██% $5M x x
JANX ██% $948M x 1.0x
JAZZ ██% $15.81B 536.1x 3.5x
JBIO ██% $1.21B x 4.1x
JNJ ██% $640.25B 30.4x 7.5x
JUNS ██% $6M x x
KALA ██% $12M x 1.2x
KALV ██% $1.38B x x
KAPA ██% $7M x 1.3x
KAYS ██% $210K x x
KMDA ██% $403M x x
KNSA ██% $4.86B 66.5x 8.0x
KPRX ██% $10M x 0.7x
KPTI ██% $160M x x
KROS ██% $201M x 0.7x
KRRO ██% $155M x 1.3x
KTTA ██% $15M x 0.3x
KURA ██% $825M x 7.6x
KYNB ██% $29M 0.2x x
LAB ██% $300M 3.8x 0.5x
LBRX ██% $997M x 2.6x
LEGN ██% $3.73B x x
LEXX ██% $13M x 2.7x
LFCR ██% $163M x x
LFVN ██% $80M 10.2x 2.4x
LGND ██% $5.96B 38.8x 6.0x
LGVN ██% $19M x 1.2x
LIANY ██% $12M x 0.1x
LIFD ██% $3M x 0.4x
LIPO ██% $150K x 0.1x
LITS ██% $34M x 0.6x
LIXT ██% $120M x 15.2x
LKFT ██% $1.85B x x
LLY ██% $1.09T 43.3x 35.1x
LNAI ██% $10M x x
LPCN ██% $16M x 0.7x
LQDA ██% $7.46B 334.2x 68.7x
LRMR ██% $394M x 2.5x
LSTA ██% $13M x 1.2x
LTRN ██% $36M x 10.3x
LXRX ██% $994M x 4.9x
LYEL ██% $302M x 1.1x
MAIA ██% $78M x 2.8x
MANE ██% $4.65B x 11.9x
MBIO ██% $4M x 0.5x
MBRX ██% $15M x 1.0x
MBX ██% $2.92B x 6.7x
MCRB ██% $47M x 1.8x
MDCX ██% $18M x 13.6x
MDGL ██% $12.70B x 23.4x
MGNX ██% $254M x 12.0x
MIRA ██% $37M x 4.0x
MIRM ██% $6.96B x 28.7x
MIST ██% $133M x 3.7x
MLTX ██% $1.69B x 6.7x
MLYS ██% $2.24B x 3.5x
MNKD ██% $1.22B x x
MNOV ██% $65M x 1.7x
MNPR ██% $739M x 5.5x
MPLT ██% $448M x 1.1x
MREO ██% $48M x 1.4x
MRK ██% $323.24B 36.2x 7.1x
MRKR ██% $20M x 1.5x
MRVI ██% $2.47B x 11.7x
MSLE ██% $197M x x
MTNB ██% $2M x 0.7x
MTVA ██% $7M x 0.8x
NAMS ██% $3.52B x 5.3x
NATR ██% $362M 18.2x 2.2x
NBP ██% $206M x 0.8x
NBTX ██% $1.95B x x
NCEL ██% $19M x 35.7x
NCNA ██% $5M x x
NERV ██% $184M x x
NEUP ██% $21M x 0.7x
NGNE ██% $691M x 2.9x
NIKA ██% $806M x x
NKTR ██% $2.41B x 4.2x
NKTX ██% $168M x 0.6x
NMAD ██% $81M x 10.2x
NNVC ██% $39M x 4.3x
NRIX ██% $2.43B x 6.0x
NRSN ██% $21M x x
NRXP ██% $155M x x
NSRX ██% $36M x 13.1x
NTHI ██% $85M x x
NUVB ██% $2.31B x 7.2x
NUVL ██% $9.75B x 8.3x
NVCT ██% $616M x 43.3x
NVS ██% $297.88B x x
NWBO ██% $273M x x
NXTC ██% $21M x 0.8x
NXTS ██% $2M x 0.2x
OCUL ██% $1.89B x 3.3x
OGEN ██% $2M x 0.4x
OGI ██% $132M x x
OGN ██% $3.56B 14.5x 3.9x
OKUR ██% $164M x 0.9x
OLMA ██% $1.05B x 2.2x
OMER ██% $816M 9.5x x
ONC ██% $33.81B 65.9x 7.1x
ONCO ██% $3M x 0.3x
ONCY ██% $93M x x
OPK ██% $937M x 0.8x
ORGO ██% $328M 120.7x 1.3x
ORIC ██% $1.24B x 3.0x
ORKA ██% $5.44B x 11.2x
ORMP ██% $170M 1.6x 0.7x
OSTX ██% $70M x x
OTLC ██% $18M x 0.1x
OVID ██% $439M x 2.2x
OWPC ██% $70K x x
PAHC ██% $1.43B 15.0x 4.0x
PBH ██% $2.44B 12.8x 1.3x
PBM ██% $12M x x
PBYI ██% $407M 16.7x 3.2x
PCRX ██% $1.04B 202.5x 1.6x
PCSA ██% $7M x 2.7x
PCYN ██% $2M x 1.0x
PDSB ██% $39M x 9.9x
PEPG ██% $131M x 1.0x
PFE ██% $140.40B 18.7x 1.6x
PGEN ██% $1.93B x 95.3x
PHAT ██% $949M x x
PHIO ██% $12M x 0.7x
PHVS ██% $2.37B x x
PKTX ██% $3M x 10.3x
PLRX ██% $67M x 0.4x
PLYX ██% $93M x 37.3x
PMHS ██% $2M x x
PMN ██% $105M x 1.7x
PMVP ██% $63M x 0.7x
PPBT ██% $1M x x
PPCB ██% $3M x 0.3x
PRAX ██% $8.80B x 6.2x
PRFX ██% $3M x 0.4x
PRGO ██% $1.40B x 0.6x
PRLD ██% $321M x 5.3x
PRPH ██% $840K x 0.1x
PRQR ██% $244M x x
PRTA ██% $462M x 1.5x
PTCT ██% $6.28B x x
PTGX ██% $8.71B x 13.3x
PTIX ██% $420K x x
PTN ██% $14M x 1.3x
PTPI ██% $170K 0.0x 0.1x
PULM ██% $6M x 1.8x
PVCT ██% $25M x x
PVLA ██% $2.03B x 8.7x
PYXS ██% $183M x 5.9x
QNRX ██% $9M x 1.0x
QNTM ██% $19M x x
QTTB ██% $452M 13.6x 9.8x
QUCY ██% $25M x 5.5x
QURE ██% $2.41B x 16.1x
RADX ██% $29M x x
RANI ██% $111M x 3.9x
RAPP ██% $2.01B x 4.3x
RARE ██% $2.64B x x
RCKT ██% $355M x 1.5x
RCUS ██% $3.49B x 6.7x
RDY ██% $9.82B x x
REGN ██% $69.39B 15.7x 2.2x
REVB ██% $4M x 0.3x
RFL ██% $121M x 1.6x
RGBP ██% $50K x x
RIGL ██% $688M 1.9x 1.7x
RKTO ██% $17M x 4.1x
RLMD ██% $546M x 2.5x
RLYB ██% $86M x 1.7x
RMHI ██% $25M x x
RMTI ██% $29M x 0.8x
RNAC ██% $212M x x
RNAZ ██% $5M x 4.0x
RNTX ██% $67M x 5.8x
RNXT ██% $42M x 3.7x
ROIV ██% $25.01B x 5.5x
RPRX ██% $33.82B 40.9x 4.9x
RTEZ ██% $1.93B x x
RVPH ██% $7M x 0.4x
RVRC ██% $101M x 16.5x
RYTM ██% $7.26B x 59.1x
RZLT ██% $478M x 4.1x
SBFM ██% $2M x 0.1x
SCNX ██% $15M x 0.2x
SCYX ██% $284M x 6.9x
SDEV ██% $30M 0.1x 0.2x
SDGR ██% $1.13B x 3.6x
SEPN ██% $1.50B x 4.0x
SER ██% $31M x 1.8x
SGMT ██% $460M x 4.5x
SHPH ██% $2M x 0.5x
SIGA ██% $222M 11.0x 1.5x
SILO ██% $5M x 0.9x
SION ██% $2.05B x 7.1x
SKVI ██% $1M x x
SKYE ██% $22M x 2.4x
SLGL ██% $259M x 11.4x
SLN ██% $570M x 11.5x
SLS ██% $1.97B x 18.3x
SMMT ██% $10.39B x 16.5x
SMNR ██% $145M x x
SNDX ██% $1.80B x 43.1x
SNGX ██% $5M x 1.7x
SNSE ██% $31M x x
SNY ██% $108.63B x x
SPRB ██% $116M x 3.3x
SPRC ██% $3M x x
SPRO ██% $70M 4.6x 1.3x
SPRY ██% $572M x 9.3x
SRPT ██% $1.67B 25.8x 1.1x
STOK ██% $1.85B x 4.7x
STTK ██% $670M x 7.0x
SUPN ██% $2.73B x 2.5x
SVRA ██% $1.10B x 6.2x
SXTP ██% $4M x 0.8x
SYBX ██% $7M x 0.6x
SYRE ██% $7.58B x 11.3x
TAK ██% $56.43B x x
TBPH ██% $870M 7.6x 3.0x
TCRT ██% $4M x 3.5x
TELO ██% $82M x 16.5x
TENX ██% $411M x 3.6x
TEVA ██% $36.52B 23.3x 4.4x
TGTX ██% $8.54B 18.5x 14.7x
TLPH ██% $63M x 3.4x
TLX ██% $3.41B x x
TNGX ██% $4.16B x 10.6x
TNXP ██% $161M x 0.7x
TOVX ██% $10M x 0.6x
TPST ██% $15M x 17.9x
TRDA ██% $228M x 0.8x
TRVI ██% $2.32B x 13.5x
TTRX ██% $238M x 38.9x
TVRD ██% $23M x 1.6x
TVTX ██% $5.16B x 52.2x
TXMD ██% $24M 131.9x 0.9x
TYRA ██% $1.85B x 4.8x
UNCY ██% $126M x 3.4x
UPB ██% $333M x 1.1x
URGN ██% $1.99B x x
UTHR ██% $26.28B 20.4x 4.5x
VBIO ██% $890K x 0.1x
VCNX ██% $3M x x
VERA ██% $2.40B x 4.8x
VGLS ██% $240K x x
VICP ██% $47M x x
VKTX ██% $3.84B x 7.6x
VNDA ██% $308M x 1.1x
VRCA ██% $99M x 6.2x
VRDN ██% $1.99B x 3.1x
VREOD ██% $491M x 1.7x
VREOF ██% $491M x 1.7x
VRTX ██% $122.80B 28.3x 6.3x
VSTM ██% $542M x 6.6x
VTGN ██% $9M x 0.3x
VTRS ██% $20.60B x 1.4x
VYNE ██% $19M x 0.8x
WHWK ██% $166M x 1.4x
WVE ██% $1.13B x 2.2x
XBIO ██% $6M x 0.8x
XBIT ██% $70M x 0.5x
XCUR ██% $10M x 5.0x
XENE ██% $6.29B x 4.7x
XERS ██% $1.43B 118.9x 109.8x
XLO ██% $60M x 0.8x
XNCR ██% $1.44B x 2.8x
XOMA ██% $710M 21.0x 7.7x
XTLB ██% $7M x x
ZBIO ██% $2.03B x 6.0x
ZLAB ██% $2.10B x 3.2x
ZNTL ██% $322M x 1.8x
ZTS ██% $32.57B 12.3x 10.1x
ZVRA ██% $568M 4.6x 2.8x
ZVSA ██% $940K x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Cadrenal Therapeutics, Inc. Stock Forecast

How accurate are Cadrenal Therapeutics, Inc. stock predictions?

Our AI model shows a 2% Spearman correlation coefficient for CVKD predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Cadrenal Therapeutics, Inc. stock price forecasts?

Our analysis considers Cadrenal Therapeutics, Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Cadrenal Therapeutics, Inc. a good investment in 2025?

Based on our AI analysis, Cadrenal Therapeutics, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Cadrenal Therapeutics, Inc. forecasts updated?

Cadrenal Therapeutics, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Cadrenal Therapeutics, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...